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Abstract 
In Australia, due to increased uncertainties over security of water supply because of 
unpredictable drought and flood cycles, alternative water sources are being investigated 
for commercial, agricultural, industrial and domestic supply, including the option of 
reusing treated sewage effluents. However, sewage effluent is a known source of 
estrogenic endocrine disrupting chemicals (EDCs) in the environment. Exposure to 
sewage effluents containing steroid estrogens and xenoestrogens can cause 
developmental and behavioural reproductive abnormalities in fish and other aquatic 
animals. As such, risk of endocrine disruption is one of the water quality issues that 
needs to be evaluated when assessing the appropriate level of treatment required for 
reuse applications. The Gerringong-Gerroa sewage treatment plant (GGSTP), currently 
employs advanced tertiary treatment technology to treat domestic sewage from two 
small coastal towns (Gerringong and Gerroa), which receive large seasonal influxes of 
holiday makers. In this study, the efficacy of the treatment at the GGSTP in removing 
estrogenically active chemicals was assessed using a multi-tiered assessment approach, 
incorporating chemical analysis, in vitro bioassays and in vivo fish exposure studies. 
The raw sewage influent was found to contain steroidal estrogens; 17~-estradiol (E2), 
estrone (E 1) and estriol (E3) as well as synthetic phenolic xenoestrogens; 4-tert-
octylphenol, Bisphenol A and technical nonylphenol at concentrations commonly found 
in sewage influents. The influent also displayed high levels of activity in the two-hybrid 
yeast in vitro bioassay. However, the final effluent had no detectable concentrations of 
steroidal estrogens, no estrogenic activity in the two-hybrid yeast assay and only 
infrequent occurrence of low concentrations of synthetic phenols. Biodegradation by 
activated sludge treatment provided significant, but incomplete removal of measured 
EDCs and estrogenic activity, with the in-line combination of ozone oxidation and 
biologically activated carbon filtration reducing the remaining estrogenic activity to 
undetectable levels. EDCs in both the dissolved and particulate phases of the effluent 
were removed by the treatment process and the efficacy of treatment was not 
compromised by increases in influent flow during the peak holiday seasons. Treatment 
of the effluent at the GGSTP was also successful at reducing retinoic acid receptor 
xv ii 
(RAR) activity and genotoxicity to below detection limits and greatly reducing 
arylhydrocarbon receptor (AhR) activity. 
On-site real-time exposure tests using the mosquito fish ( Gambusia holbrooki) and 
rainbowfish (Melanotaenia jluviatilis) demonstrated that the final effluent did not elicit 
up-regulation of vitellogenin, a well known biomarker of exposure to estrogenic EDCs. 
Despite the presence of residual concentrations of E 1 and the in vitro activity in effluent 
after being processed through activated sludge treatment, clarification and 
sandfiltration, vitellogenin up-regulation was not detected in fish exposed to this 
partially treated effluent. Overall, the results provide evidence that the application of 
advanced tertiary treatment technology to domestic sewage can produce a final effluent 
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